Skip to main content
. 2015 Feb 17;6(7):4888–4900. doi: 10.18632/oncotarget.2917

Figure 6. Attenuation of diminished viability, apoptosis, and telomere shortening by ectopic TERT expression in 5-AZA-treated HEL cells.

Figure 6

HEL-TERT and HEL-pBMN cells were treated with 5-AZA at different concentrations for up to 72 hours (3 days), and then analyzed for cell number, viability, and apoptosis and telomere length. (A) and (B) The number and viability of HEL-TERT and HEL-pBMN cells in the presence of 5-AZA at various concentrations and time periods, respectively. (C) Differences in apoptosis of HEL-TERT and HEL-pBMN cells in the presence of 5-AZA at various concentrations. * denotes P < 0.05. (D) Telomere length in 5-AZA-treated HEL-TERT cells as determined using FLOW-FISH. The values are means ± SD. Three independent experiments were performed.